13D/13G Filings - Viridian Therapeutics Inc. (VRDN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-11
5:15 pm
Purchase
2025-04-04 13G Viridian Therapeutics, Inc.
VRDN
Commodore Capital LP 4,300,000
5.300%
2,375,926increase
(+123.48%)
Filing
History
2025-02-14
6:05 pm
Unchanged
2024-12-31 13G Viridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III L.P. 3,575,309
4.500%
0
(Unchanged)
Filing
History
2024-11-14
5:53 pm
Sale
2024-09-30 13G Viridian Therapeutics, Inc.
VRDN
Venrock Opportunities Fund L.P. 1,882,615
2.900%
-941,306decrease
(-33.33%)
Filing
History
2024-11-14
5:52 pm
Sale
2024-09-30 13G Viridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III L.P. 3,575,309
5.500%
-1,980,259decrease
(-35.64%)
Filing
History
2024-11-14
4:50 pm
Sale
2024-09-30 13G Viridian Therapeutics, Inc.
VRDN
PERCEPTIVE ADVISORS LLC 2,812,665
3.800%
-1,209,401decrease
(-30.07%)
Filing
History
2024-11-14
4:33 pm
Sale
2024-09-30 13G Viridian Therapeutics, Inc.
VRDN
Paradigm BioCapital Advisors LP 3,509,253
4.600%
-1,795,060decrease
(-33.84%)
Filing
History
2024-10-18
12:33 pm
Sale
2024-09-30 13G Viridian Therapeutics, Inc.
VRDN
STATE STREET CORP
STT
2,379,774
3.200%
-328,609decrease
(-12.13%)
Filing
History
2024-09-17
9:00 pm
Purchase
2024-09-13 13D Viridian Therapeutics, Inc.
VRDN
Fairmount Funds Management LLC 15,556,685
17.950%
1,600,000increase
(+11.46%)
Filing
History
2024-04-01
6:38 pm
Unchanged
2024-03-28 13D Viridian Therapeutics, Inc.
VRDN
Fairmount Funds Management LLC 13,956,685
18.640%
0
(Unchanged)
Filing
History
2024-02-14
8:28 pm
Purchase
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III L.P. 5,555,568
9.990%
1,324,947increase
(+31.32%)
Filing
History
2024-02-14
4:08 pm
Purchase
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
Paradigm BioCapital Advisors LP 5,304,313
9.990%
2,993,615increase
(+129.55%)
Filing
History
2024-02-14
4:05 pm
Purchase
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
Commodore Capital LP 1,924,074
3.700%
552,735increase
(+40.31%)
Filing
History
2024-02-14
09:22 am
Sale
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-2,302,094decrease
(Position Closed)
Filing
History
2024-02-14
09:01 am
Purchase
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
Deep Track Capital, LP 5,378,997
9.900%
2,066,023increase
(+62.36%)
Filing
History
2024-02-13
5:17 pm
Purchase
2023-12-29 13G Viridian Therapeutics, Inc.
VRDN
The Vanguard Group 3,000,948
5.710%
885,954increase
(+41.89%)
Filing
History
2024-01-29
4:53 pm
Purchase
2024-01-18 13G Viridian Therapeutics, Inc.
VRDN
PERCEPTIVE ADVISORS LLC 4,022,066
6.700%
4,022,066increase
(New Position)
Filing
History
2024-01-29
3:26 pm
Purchase
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
BLACKROCK INC
BLK
3,426,450
6.500%
664,894increase
(+24.08%)
Filing
History
2024-01-24
5:12 pm
Purchase
2024-01-22 13D Viridian Therapeutics, Inc.
VRDN
Fairmount Funds Management LLC 13,956,685
19.430%
1,192,292increase
(+9.34%)
Filing
History
2024-01-24
08:13 am
Purchase
2023-12-31 13G Viridian Therapeutics, Inc.
VRDN
STATE STREET CORP
STT
2,708,383
5.150%
2,708,383increase
(New Position)
Filing
History
2024-01-10
08:53 am
Purchase
2024-01-09 13G Viridian Therapeutics, Inc.
VRDN
FMR CORP 7,625,542
14.501%
7,625,542increase
(New Position)
Filing
History
Goto 0, 1, 2, 3, Next